• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store

CMS Mulls Automatic Medicare Coverage of MCIT Breakthrough Devices

by Glenn S. Demby | May 10, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Reimbursement-dtet

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
CMS Mulls Automatic Medicare Coverage of MCIT Breakthrough Devices

CMS Mulls Automatic Medicare Coverage of MCIT Breakthrough Devices

by Glenn S. Demby | May 6, 2021 | Blog, News, Open Content

Manufacturers of innovative medical devices are on pins and needles right now. That is because the Centers for Medicare and Medicaid Services (CMS) delayed implementation of a final rule that was supposed to take effect on March 15, 2021 that would have ensured at...
Silicon Valley Becomes Epicenter of Lab Investment Scams

Silicon Valley Becomes Epicenter of Lab Investment Scams

by Glenn S. Demby | May 1, 2021 | Blog, News, Open Content

On paper, the Silicon Valley venture capital and innovation that have lifted so many other industries seem like the perfect elixir for medical labs. Perhaps one day it will prove to be just that. But so far at least, things haven’t gone well. Instead of driving...
The Evolving COVID-19 Market: FDA Clears the Way for Asymptomatic Screening Products

The Evolving COVID-19 Market: FDA Clears the Way for Asymptomatic Screening Products

by Glenn S. Demby | Apr 4, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Silicon Valley Becomes Epicenter of Lab Investment Scams

COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million

by Glenn S. Demby | Apr 3, 2021 | Articles, Earnings-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com